Hungarian Regulatory Submission Translation: 26 Cases and EU Compliance
Hungarian regulatory translation comes with a few traps. An English technical dossier may be acceptable, but the Hungarian patient leaflet still needs to be right. The same goes for device instructions and safety updates. Here are 26 situations where translation comes into play, along with the requirements companies should check before submitting documents in Hungary.
Hungarian regulatory translation can get complicated when a company assumes that EU approval takes care of everything. It doesn’t. A medicine authorized through the European Medicines Agency still needs Hungarian product information before it can be marketed in Hungary. Medical devices have their own rules, and the language requirements aren’t always the same. The trick is knowing which documents need translating and which can stay in English.
There’s also the question of timing. Companies sometimes finish their English documents before finding out that the Hungarian leaflet needs another round of work. Now the packaging team is waiting, and someone has to figure out which version was approved. A little planning for EU regulatory submission translation can prevent that kind of mess, especially when several European markets are involved.
Why Hungarian Translation Matters for EU Regulatory Submissions
Hungary is part of the EU, so pharmaceutical companies and medical device manufacturers work under European regulations. Still, Hungary has a say in what language certain documents must use. That’s why a company can have perfectly acceptable English technical documentation and still need Hungarian translations for its product.
The role of Hungarian in EU-wide pharmaceutical and device filings
Hungarian is one of the EU’s official languages. For centrally authorized medicines, the approved product information is prepared in the required EU languages, including Hungarian.
Medical devices work differently. Manufacturers follow the EU MDR, but the language of instructions supplied with a device depends on the country where it will be sold or used. In Hungary, that generally means Hungarian information for users.
How national language requirements interact with centralized procedures
An EU-wide marketing authorization is strict with pharmaceutical companies permission language requirements. The centralized procedure brings the scientific assessment together, but the product information still has to be prepared for individual EU markets.
Devices don’t go through the EMA’s centralized medicine authorization procedure. Instead, manufacturers follow the relevant conformity assessment process and check the language requirements of each country.
Why accurate Hungarian translation supports faster review and market access
Suppose a company changes a medicine’s dosage instructions during regulatory review. The English document is corrected, but nobody updates the Hungarian leaflet. By the time the mistake is discovered, the packaging artwork has already been prepared.
Now the team has to correct the leaflet and check whether the packaging needs another revision. Accurate translations won’t make regulators approve a product faster, but they can prevent avoidable delays like this one.
Regulatory Context: Hungary and the EU Framework
One thing worth understanding before starting a translation project is that pharmaceuticals and medical devices don’t follow the same approval system. Even the Hungarian authority named in older regulatory files may no longer be the one handling the work today.
The relationship between EMA, EU MDR, and national authorities
The EMA coordinates the scientific evaluation of medicines submitted through the centralized procedure. Following that assessment, the European Commission decides whether to grant the marketing authorization.
For medical devices, the EU MDR sets the rules. Depending on the device’s classification, a notified body may need to assess its conformity before it can be placed on the market.
Hungarian authorities also have responsibilities under these systems. Their involvement depends on the product and the procedure being followed.
The role of OGYÉI in Hungarian pharmaceutical and device oversight
OGYÉI was the National Institute of Pharmacy and Nutrition in Hungary. Companies may still encounter the name in older documents or when searching for OGYÉI translation services.
The institution was integrated into the National Center for Public Health and Pharmacy (NNGYK) in 2023. As a result, businesses should check current Hungarian authority information before preparing a submission.
Older templates can be useful references, but copying an outdated authority name into a new document is an unnecessary mistake.
How EU language requirements apply to Hungary
EU legislation doesn’t require every technical document to be translated into all official languages. The requirements change depending on the document and the regulatory procedure.
For instance, an English clinical report may be acceptable in a pharmaceutical submission, while the Hungarian patient leaflet is required for the local market.
With medical devices, EU MDR Article 10(11) allows Member States to determine the language requirements for information supplied with devices. Manufacturers planning to sell in Hungary need to check those national rules rather than assuming that English instructions will be enough.
The 26-Case Perspective: Understanding Common Submission Scenarios
Hungarian translation isn’t something companies deal with only when applying for their first approval. Documents keep changing after products reach the market, and some changes bring new translation work.
The following 26 cases show where Hungarian translations may be needed. They aren’t 26 separate legal obligations. In several situations, English is acceptable, so the first job is to find out what the procedure actually requires.
1. Initial marketing authorization applications
When a pharmaceutical company applies for its first marketing authorization, it submits information about the medicine for regulatory assessment. Much of the scientific dossier may be prepared in English.
Hungarian product information is another matter. If the medicine will be marketed in Hungary, the required Hungarian versions must be prepared under the applicable authorization procedure. Starting this work early gives translators time to handle changes made during regulatory review.
2. Variations and post-approval changes
A medicine can sell for years before a manufacturer makes certain changes (change in the side effect warning or a new formula).
That change must be approved by regulators. With that, Hungarian documents must be updated too, and the translator needs to work with the new approved version.
3. Renewals and periodic safety updates
When a medicine is renewed, it needs new safety reports, which can often stay in English. But if regulators approve a new warning, the Hungarian SmPC needs to include it. Everything that includes information that can eventually affect the patient needs an update.
4. Clinical trial applications and amendments
While some clinical trial documents can stay in English, Hungarian participants need consent forms they can understand. If researchers add another hospital visit or change the study schedule, the Hungarian documents must reflect those changes before participants sign them.
5. Medical device registrations and conformity assessments
A manufacturer must meet the EU MDR requirements for a specific product before even trying to sell a medical device in Hungary.
The language requirements aren’t the same for every document. Instructions given to Hungarian users generally need to be in Hungarian, while a notified body may accept the manufacturer’s technical documentation in English. Translating the entire technical file without checking first could mean paying for work that wasn’t required.
6. National labeling and patient information requirements
Hungarian labeling translation is challenging, especially when the packaging has already been designed for the English text. A text that fits well on the original box may take much more space in Hungarian.
Medicine packaging and patient leaflets need the information in Hungarian. If the wording doesn’t fit, the designer has to find more room for it. Cutting a warning short to squeeze it onto a small box should never be the option.
7. Referral procedures and multi-country reviews
When a safety concern or disagreement about a medicine’s authorization affects several EU countries, regulators may use a referral procedure to reach a common decision.
If the procedure results in new product information, companies may have to update their Hungarian documents. The revised translation should follow the agreed regulatory wording, even when the company already has an older Hungarian version.
8. Orphan designation and pediatric investigation plans
Orphan designation and pediatric investigation plans are part of EU pharmaceutical regulation. They don’t automatically create a requirement to translate the complete application into Hungarian.
Translation may become necessary later when the medicine moves toward authorization and marketing in Hungary. Companies should separate the requirements of the EU procedure from those of the local market.
9. Biosimilar and generic submissions
Generic and biosimilar medicines follow specific authorization requirements, but they still need appropriate Hungarian product information when marketed in Hungary.
Established terminology can be particularly useful here. Translators should check the approved wording rather than inventing new Hungarian expressions for substances that already have recognized names.
10. Pharmacovigilance and risk management documentation
Pharmacovigilance work continues after a medicine is approved. Companies collect safety information and report it under the applicable rules.
Many technical reports can remain in English. However, risk-minimization materials intended for Hungarian healthcare professionals or patients may require Hungarian translation.
A safety brochure written for patients needs a different approach from a report intended for regulators.
11. Device summaries of safety and clinical performance
Under the EU MDR, certain medical devices require a summary of safety and clinical performance.
This document gives users and, where relevant, patients access to important information about the device. Manufacturers must follow the applicable requirements for its preparation and language availability.
A summary shouldn’t simply copy difficult technical passages from the full clinical evaluation report without considering its intended readers.
12. Field safety notices and corrective actions
Imagine a manufacturer discovers that a medical device requires a safety correction after being distributed in Hungary.
The company may need to send a field safety notice explaining the issue and what users must do. The Hungarian version should be checked carefully against the original, particularly where the notice gives instructions for continued use or corrective action.
13. Import, distribution, and local representative documentation
Companies selling products in Hungary may need documents concerning distribution arrangements or regulatory responsibilities.
Some of these documents may require Hungarian translation, depending on their purpose and the receiving organization.
A commercial distribution agreement and a regulatory notification are different documents, so companies shouldn’t assume they follow identical language rules.
14. Advertising and promotional material reviews
Pharmaceutical advertising in Hungary must comply with the applicable rules on promotional claims.
A translation can create problems when it makes a product sound more effective than the approved information supports. Hungarian promotional material should therefore be checked against the authorized product information.
Even a small change in wording can make a claim stronger than the original.
15. Patent and supplementary protection documentation
Patent documents and supplementary protection certificates fall under intellectual property procedures rather than ordinary pharmaceutical authorization.
Hungarian translations may be necessary for certain national filings or proceedings. The requirements should be confirmed with the relevant patent professionals before translation begins.
16. Pricing and reimbursement submissions
Marketing authorization allows a medicine to be marketed under the conditions of its approval, but reimbursement is a separate matter.
Companies seeking reimbursement in Hungary may need Hungarian application materials and supporting information.
The requirements come from the relevant pricing and reimbursement procedure, not automatically from the original EMA authorization.
17. Quality and manufacturing documentation
Manufacturing documents describe how a pharmaceutical product is produced and controlled.
Much of this information may be accepted in English for regulatory purposes. When a Hungarian version is requested, the translator needs enough technical knowledge to understand the manufacturing terminology.
A familiar English word can have a much more specific meaning in a production document.
18. Stability and analytical method translations
Stability studies show how a medicine behaves under defined storage conditions. Analytical methods explain how its quality is tested.
These documents can contain measurements and specialized expressions that require close attention.
When Hungarian translation is necessary, the reviewer should compare the technical information directly with the original rather than relying on how natural the finished sentence sounds.
19. Investigator brochures and informed consent forms
An investigator brochure is written for clinical researchers. An informed consent form is written for people considering participation in a study.
Their Hungarian translations shouldn’t sound alike. The brochure may contain advanced medical terminology, while the consent form needs language that participants can understand without specialized training.
20. Device instructions for use and operator manuals
Medical device instructions explain how a product should be used.
For devices placed on the Hungarian market, the applicable language requirements generally call for Hungarian user information, subject to relevant exceptions.
Manufacturers should also check whether the translated instructions match the actual device interface. A button described in the manual must be identifiable on the product.
21. Technical file summaries for national authorities
A Hungarian authority may request information from a manufacturer’s technical documentation.
Whether a translation is needed depends on the request and the applicable procedure. Sometimes an English technical document is acceptable, while a Hungarian summary or explanation may be required.
Confirming the scope first can save the company from translating hundreds of unnecessary pages.
22. Post-market surveillance reports
Post-market surveillance helps manufacturers understand how their devices perform after being placed on the market.
The EU MDR establishes reporting obligations, but not every report automatically requires a complete Hungarian translation.
Local communication or a specific authority request may create additional language needs.
23. Incident and adverse event reporting
Reports about medical device incidents and suspected adverse reactions to medicines follow different regulatory systems.
When Hungarian translation is required, the original account must be represented accurately. A report stating that an event may be related to a product shouldn’t become a definite claim that the product caused it.
6. National labeling and patient information requirements
A manufacturer must meet the EU MDR requirements for a specific product before even trying to sell a medical device in Hungary.
The language requirements aren’t the same for every document. Instructions given to Hungarian users generally need to be in Hungarian, while a notified body may accept the manufacturer’s technical documentation in English. Translating the entire technical file without checking first could mean paying for work that wasn’t required.
24. Recalls and safety communications
Recalls can require companies to contact Hungarian healthcare providers or product users quickly.
A translated notice must make the required action understandable. If the original says to stop using a particular batch, the Hungarian communication needs to identify that batch correctly.
Confusing instructions can make an already difficult situation worse.
25. Device registration notifications
Medical device manufacturers may have national notification obligations alongside applicable EU registration requirements.
The exact documentation depends on the device and the current regulatory framework. Companies should verify the Hungarian requirements before preparing translations.
Older registration instructions may no longer reflect the current process.
26. Cross-border referral and harmonization procedures
A regulatory decision affecting several EU countries may require coordinated updates to national product information.
Hungarian documents need to reflect the agreed outcome while meeting the requirements of the relevant procedure.
Problems often begin when different country teams work from different source versions. Keeping the approved English wording under control makes those updates easier to manage.
Pharmaceutical Translation Requirements for Hungary
Pharmaceutical submissions contain documents written for different readers. A clinical study report isn’t meant to sound like a patient leaflet, and the translation requirements aren’t necessarily the same either.
For pharmaceutical translation Hungarian projects, companies should first identify which files are intended for regulatory assessment and which will accompany the medicine when it reaches the market.
SmPC, PIL, and labeling in Hungarian
The Summary of Product Characteristics (SmPC) gives healthcare professionals the approved information about a medicine. The Patient Information Leaflet (PIL) explains how patients should use it.
Both generally need Hungarian versions for medicines marketed in Hungary. The packaging must also carry the required Hungarian information.
A common headache appears when the SmPC changes but the leaflet doesn’t. Someone has to compare the documents and make sure the patient instructions still reflect the approved information.
CTD modules and supporting technical documentation
The Common Technical Document (CTD) organizes the information companies submit when applying for pharmaceutical authorization.
Many scientific sections can remain in English, depending on the procedure. Hungarian translations may be needed for certain administrative documents or approved product information.
Translating the entire dossier without checking the requirements first can create a large bill for work nobody requested.
Clinical protocols, reports, and safety summaries
Clinical reports are full of terminology that can be misunderstood by someone unfamiliar with pharmaceutical research.
When translation is required, the translator must understand what the study actually measured. An endpoint, for example, has a specific meaning in clinical research that shouldn’t be replaced with an approximate everyday expression.
English may still be accepted for these documents in the relevant submission procedure.
Quality, nonclinical, and clinical sections requiring Hungarian
The quality section describes the medicine’s composition and manufacturing controls. Nonclinical and clinical sections provide evidence used to evaluate the product.
These scientific sections aren’t automatically required in Hungarian simply because the product will be marketed there.
If an authority requests a translation, the company should establish exactly which material is needed. That avoids unnecessary work and makes the review easier to organize.
Maintaining consistency across the entire submission package
Imagine one translator uses an established Hungarian name for an active substance while another chooses a different expression.
Both translations might seem reasonable, but now the company has two names appearing in related documents.
A terminology list based on approved product information can prevent this. It should be available to everyone working on the Hungarian submission.
Medical Device Translation Requirements for Hungary
Medical devices come with their own translation problems. A manufacturer may have an English technical file accepted during conformity assessment but still need Hungarian instructions for the people using the device.
The applicable EU MDR requirements and Hungarian national rules determine what must be translated.
Instructions for use in Hungarian under EU MDR
Under the EU MDR, manufacturers must provide the required device information in the language determined by the Member State where the product is made available.
Hungarian instructions for use are generally necessary for devices supplied in Hungary, subject to the applicable rules and exceptions.
Translators also need to understand the device. A poorly translated instruction can leave an operator unsure which setting to select.
Labels, packaging text, and warnings
Device labels often leave little room for translation. Hungarian words can also become longer when suffixes are added.
That creates a practical problem for packaging designers, but the solution can’t be to remove important information.
The translated warning needs to remain accurate, even if the layout has to change to accommodate it.
Declarations of conformity and summary documents
An EU declaration of conformity is the manufacturer’s formal statement that the device meets the applicable requirements.
Its language must follow the rules of the Member State concerned. Other summary documents may have different requirements.
Before translating these files, manufacturers should check which Hungarian versions are necessary and whether any approved terminology already exists.
Clinical evaluation and performance summaries
A clinical evaluation report examines the evidence supporting a medical device’s safety and performance.
Certain devices also require a summary of safety and clinical performance under the EU MDR.
These documents serve different purposes. The full report is technical, while the summary is intended to make relevant information accessible to a wider audience. Translation should reflect that distinction.
Post-market surveillance and safety documentation
Manufacturers must continue monitoring their devices after placing them on the market.
A post-market surveillance report may remain in English under the applicable arrangements. However, a safety notice distributed to Hungarian users may need a Hungarian version.
The translation team should check the audience and regulatory purpose before deciding how to handle each document.
Clinical Trial Documentation in Hungarian
Clinical trials conducted in Hungary involve documents for researchers and information intended for participants.
Someone deciding whether to join a trial shouldn’t have to understand the language of a medical research paper. That’s why participant documents need particular attention.
Informed consent forms for Hungarian trial sites
Informed consent forms explain what participation in a study involves.
Hungarian participants need information they can understand before deciding whether to take part. The translation must accurately explain the study without making the wording unnecessarily complicated.
A technical phrase may need to be expressed in ordinary Hungarian, provided the original meaning remains intact.
Participant information sheets and recruitment materials
Recruitment materials introduce a study to potential participants.
The Hungarian version must not promise benefits that the original document doesn’t support. It also needs to explain participation requirements clearly.
A phrase that sounds harmless in English can become misleading if the translator chooses wording that makes an experimental treatment sound like an established one.
Investigator brochures and trial protocols
An investigator brochure contains information about the investigational product. The protocol explains how the study is supposed to work.
These documents may be accepted in English for submission, depending on the applicable requirements.
When Hungarian translations are needed, clinical experience matters. A translator unfamiliar with trial procedures may misunderstand instructions that researchers would consider straightforward.
Safety reporting and trial amendments
Clinical trials can change after they begin. A new safety finding might require the sponsor to update information given to participants.
When an amendment affects Hungarian documents, the translation team needs the revised source material.
Working from an older consent form is risky because it may leave out information introduced by the amendment.
Aligning Hungarian versions with the master English documents
International clinical trials frequently use English master documents.
The Hungarian versions should correspond to the correct approved source. If the English document changes, the team needs to identify which translations are affected.
A clear version history is particularly helpful when several trial sites are using the same materials.
Linguistic Review and Quality Expectations
A Hungarian translation can sound perfectly natural and still contain a regulatory mistake.
For example, the terminology might differ from the approved product information. That can lead to reviewer comments even when the Hungarian grammar is correct.
EMA linguistic review for centralized products
The EMA coordinates a linguistic review process for product information associated with centrally authorized medicines.
Applicants prepare the required language versions, including Hungarian, following the applicable EMA instructions and Quality Review of Documents (QRD) templates.
During EMA linguistic review Hungarian submissions may receive comments that require corrections. Companies need to address those comments in the revised documents rather than treating the first translation as final.
National review of Hungarian product information
Medicines authorized through national procedures follow the applicable Hungarian regulatory requirements.
The national authority may review the Hungarian product information and request corrections.
Companies should check the procedure before submission because the arrangements aren’t necessarily identical to the EMA’s centralized linguistic review.
Terminology consistency across all Hungarian documents
The same medicine shouldn’t appear under different ingredient names in related documents.
Established Hungarian medical terminology should be used consistently, especially where the wording has already been approved.
A shared glossary helps translators avoid unnecessary differences. It also makes later updates easier because the team can reuse terminology that has already been checked.
Avoiding discrepancies between English and Hungarian versions
Consider an English warning that applies only to patients with a particular condition.
If the Hungarian version removes that condition, the warning now has a different meaning.
A bilingual reviewer needs to compare both texts carefully. Reading the Hungarian translation on its own won’t always reveal what has changed.
Key Challenges in Hungarian Regulatory Translation
Hungarian doesn’t build sentences the same way English does. Its grammar can make literal translation sound awkward, especially in documents filled with technical expressions.
The translator has to understand the original statement before deciding how to write it naturally in Hungarian.
Complex medical and regulatory terminology
Some medical terms have established Hungarian equivalents. Others require more attention because their meaning depends on the document.
A clinical researcher may understand a technical expression immediately, while a patient reading the same wording could struggle.
Translators should choose terminology appropriate to the document without changing the medical information.
Long compound words and technical expressions
Hungarian uses suffixes extensively. A word can carry grammatical information that English would express through several separate words.
This makes direct word-for-word translation unreliable.
An English technical phrase may need a different structure in Hungarian. The important thing is preserving the relationship between the terms rather than copying the original sentence.
Differences between scientific and patient-facing language
A pharmaceutical report can use technical language because its readers have medical training.
Patient information needs another approach.
The Hungarian leaflet should explain the medicine in language that patients can understand while remaining faithful to the approved content. Simplifying the wording shouldn’t mean leaving out a condition or changing an instruction.
Maintaining clarity without losing regulatory precision
Some regulatory expressions sound complicated because they describe a very specific requirement.
Changing the wording too freely can alter that requirement.
A translator should make the Hungarian sentence readable without broadening or narrowing the original statement. This takes more judgment than simply replacing English words with Hungarian equivalents.
Managing updates across multiple submission types
A company might be updating its Hungarian product information while preparing a separate submission in another EU country.
If the English source changes during that work, the translations may no longer match.
Version control helps the team identify which documents need another review. Otherwise, an outdated sentence can make its way into a supposedly final file.
Building a Reliable Hungarian Translation Workflow
A good translation process starts before anyone opens the first document.
The company needs to know which version is approved and which terminology should be used. Without that information, translators can spend hours correcting problems that were avoidable.
Start with a controlled Hungarian terminology base
Begin with the terminology already used in approved Hungarian product information.
Where possible, translators should reuse established names and expressions rather than creating alternatives.
A glossary becomes particularly useful when several documents are being translated at once. Everyone can refer to the same terminology instead of making independent decisions.
Use translators with EU regulatory and life sciences experience
Someone can speak excellent Hungarian and still misunderstand a pharmaceutical document.
Experience with EU regulatory procedures helps translators recognize expressions that have specific meanings.
For medical device work, familiarity with the product’s technology is also valuable. A translator needs to understand what an instruction describes before rewriting it.
Complete bilingual review and independent proofreading
Bilingual review checks whether the Hungarian translation accurately reflects the original.
Proofreading focuses on the finished Hungarian document, including whether the language reads naturally.
Both checks are useful because they catch different problems. A grammatically correct sentence can still mistranslate an important instruction.
Verify numbers, units, warnings, and cross-references
Numbers deserve a separate check during regulatory translation.
A reviewer should compare the translated values directly with the source. References to sections and tables also need attention, especially when formatting has changed.
Warnings should receive the same careful comparison. Their wording can affect how healthcare professionals or patients understand the product.
Track versions and changes across the submission lifecycle
Every new source version should have a clear identifier.
When a document changes, the project manager needs to know whether the Hungarian translation requires updating.
This becomes particularly important after approval, when companies may be maintaining several versions of product information for different markets.
Documents That Typically Require Hungarian Translation
Not every document submitted in Hungary must be translated. Some can remain in English, while others need Hungarian versions because of their intended readers or the applicable national rules.
The sensible approach is to check the requirements for each document before ordering translation.
Product information and labeling
Hungarian SmPCs and package leaflets are generally required for medicines marketed in Hungary.
The packaging must also carry the necessary Hungarian information.
These documents should match the approved product information, including any changes introduced during regulatory review.
Clinical trial and safety documentation
Informed consent forms and participant information for Hungarian trial sites generally need Hungarian translations.
Scientific trial documents may be accepted in English under the applicable procedures.
Safety information distributed locally may also require Hungarian, depending on its purpose and intended readers.
Quality and manufacturing records
Manufacturing documentation can contain detailed descriptions of production methods.
Such records don’t automatically require Hungarian translation for every submission.
If an authority requests a particular section, the company should confirm the scope before translating the material.
Device instructions and technical summaries
Medical device instructions are among the documents most likely to require Hungarian.
Technical summaries may have different language requirements, depending on the device and the regulatory procedure.
Manufacturers should check whether a complete translation is necessary or whether only certain information must be provided in Hungarian.
Pharmacovigilance and post-market reports
Safety monitoring continues after medicines and medical devices reach the market.
Many technical reports can be prepared in English under the applicable reporting systems.
Hungarian translations may be necessary when information is communicated to local users or requested through a national procedure.
Communications with Hungarian authorities
Correspondence with Hungarian authorities may be subject to national language requirements.
Before preparing a formal response, companies should confirm whether English is accepted for that particular procedure.
This can prevent unnecessary translation work and avoid having to resubmit a document in another language.
Common Mistakes That Delay Submissions
Regulatory translation problems aren’t always caused by difficult Hungarian grammar.
Sometimes the wrong file gets translated. Other times, the source changes and nobody tells the translator.
Inconsistent product names and active ingredient terms
A product name should match the relevant approved documentation.
Using a different name in the Hungarian leaflet can create confusion, especially when the same product appears in several related files.
Checking established terminology before translation begins is easier than correcting inconsistencies afterward.
Literal translations that obscure regulatory meaning
An English sentence may be perfectly clear to a regulatory specialist but sound unnatural when translated word for word into Hungarian.
The translator needs to understand what the statement means and express it using appropriate Hungarian grammar.
Copying the English structure isn’t proof of accuracy. Sometimes it makes the translation harder to understand.
Missing or incomplete Hungarian sections
An appendix can be overlooked when a large document is divided between translators.
Tables can also cause problems when their contents aren’t included in the translation files.
A final comparison with the original helps identify anything that has been missed before the document reaches the authority.
Errors in dosage, device settings, or safety warnings
A small numerical mistake can have serious consequences in pharmaceutical or medical device documentation.
Reviewers should verify the translated values against the original rather than assuming they are correct.
Device instructions also need to match the actual product. A translated setting name is no help if the operator cannot find it on the device.
Failing to update Hungarian documents after source changes
Imagine the English SmPC is revised, but the Hungarian leaflet still contains the previous wording.
The company now has two documents describing different approved information.
A reliable update process should identify affected translations whenever the source changes.
Supporting Multi-Country EU Filings
Companies working across several EU countries often use one English source document for multiple translations.
That can work well, provided everyone uses the same approved version. Problems begin when one language team receives an update that the others never see.
Coordinating Hungarian with other EU language versions
Hungarian translation may be one part of a larger multilingual project.
The team should work from approved source material and follow the terminology required for each market.
When regulators request changes, those changes need to reach the translators responsible for the affected languages.
Maintaining a single source of truth for all translations
A controlled master document gives everyone a reliable reference.
Without it, different teams may translate different versions of the same text.
Version numbers and clear revision records make it easier to determine which translation is current.
Ensuring alignment across centralized and national procedures
A centralized pharmaceutical authorization and a national procedure don’t necessarily follow identical submission arrangements.
The Hungarian materials must meet the requirements of the procedure being used.
Companies should check whether existing translations can be reused before including them in a new application.
Preparing Hungarian materials for parallel submissions
Parallel submissions can create pressure when several regulatory deadlines fall close together.
Hungarian translations should be scheduled early enough to allow for review and corrections.
Waiting until the English documents are ready for submission may leave too little time to prepare the required Hungarian versions.
How TLD Supports Hungarian Regulatory Translation
The Language Doctors provides language services for organizations working with specialized documentation.
For Hungarian regulatory projects, the translation scope should be established around the documents involved and the requirements of the relevant procedure.
Translation of pharmaceutical, clinical, and device documents
TLD supports translation projects involving pharmaceutical and medical documentation.
For specialized regulatory work, the translator’s subject knowledge matters because technical expressions may have meanings that aren’t obvious from ordinary language.
Companies should identify the regulatory purpose of the documents when requesting a translation.
Hungarian labeling, instructions for use, and patient materials
Hungarian labeling and patient information require particular attention because the finished text may be used directly by healthcare professionals or patients.
Device instructions also need to describe the product accurately.
TLD can be contacted to discuss the translation requirements for these materials and the review needed before delivery.
Terminology management and document consistency
Large regulatory projects often involve repeated terminology.
A controlled glossary can help translators use the same Hungarian expressions throughout related documents.
When a company already has approved Hungarian product information, that material should be supplied as a reference for future translations.
Multi-stage review for accuracy, consistency, and confidentiality
Regulatory documents benefit from review by someone who can compare the Hungarian translation with the original.
Independent proofreading can then identify language problems in the finished document.
Companies can discuss the appropriate review process with TLD based on the document’s technical complexity and regulatory purpose. Final regulatory acceptance remains with the relevant authorities.
FAQ:
Hungarian translations are generally needed for approved pharmaceutical product information used in Hungary and for certain medical device information supplied to users.
Other requirements depend on the regulatory procedure. English may be acceptable for many scientific and technical documents.
Hungarian versions of the SmPC, package leaflet, and required labeling are generally necessary for medicines marketed in Hungary.
Specific exceptions and procedural requirements should be checked before submission.
Generally, yes, when instructions are required for a device made available in Hungary, subject to applicable national rules and exceptions.
Manufacturers should verify the requirements for their particular device before placing it on the market.
English technical documentation may be accepted in certain regulatory procedures.
That doesn't mean every English document is automatically acceptable. The company should check the language requirements of the receiving authority or notified body.
OGYÉI was Hungary's former National Institute of Pharmacy and Nutrition. Its responsibilities were transferred to NNGYK in 2023.
Companies should consult the current competent authority's requirements rather than relying on older OGYÉI documentation.
The EMA's linguistic review process helps ensure that the required language versions of centrally authorized product information meet the applicable standards.
Applicants may need to revise Hungarian translations after receiving reviewer comments.
Informed consent forms and participant information generally need Hungarian versions for trials conducted in Hungary.
Other clinical documents may be submitted in English, depending on the applicable requirements.
Using different Hungarian terms for the same medical concept can make related documents confusing.
Consistent terminology helps readers recognize when the documents refer to the same product or information.
Machine translation may help with preliminary work, but its output shouldn't be treated as a finished regulatory translation without appropriate expert review.
A machine can produce fluent Hungarian while misunderstanding a technical expression. Documents affecting product safety need careful verification.
The Language Doctors can discuss translation requirements for Hungarian pharmaceutical and medical device documentation, including projects involving multiple EU languages.
Companies can contact TLD to explain their project and request information about the available services.
At The Language Doctors, we work with native subject-matter experts across 200+ languages, including Norwegian, trusted for certified document translation.
With our service, you can expect translators who understand the subject as well as the language, certified translation for Norwegian contracts, healthcare and immigration documents, and wording handled for what it means in context, not just what it looks like on the page.
Everything you need for the moments where “easy to learn” is not the same as “easy to translate” and a legal or medical term carries a very specific meaning. We connect you with qualified professionals who understand the terminology and certification requirements involved.
Get your free Norwegian translation consultation today. Accurate, certified and built for official documents.
